December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 27, 2025
Projections indicate that, precision medicine industry is projected to rise from USD 118.52 billion in 2025 to USD 538.83 billion by 2035, reflecting a CAGR of 16.35% over the next decade. The market is growing due to increasing demand for personalized treatments tailored to individual genetic profiles. Advancements in genomics and data analytics a...
November 27, 2025
According to market projections, the vaccine adjuvant sector is expected to grow from USD 747.6 million in 2025 to USD 1394.15 million by 2035, reflecting a CAGR of 6.43%.The market is growing due to rising demand for stronger and longer-lasting immune responses....
November 27, 2025
According to market projections, the respiratory health supplements sector is expected to grow from USD 8.78 billion in 2025 to USD 18.52 billion by 2035, reflecting a CAGR of 7.75%. The respiratory health supplements market is growing due to rising pollution leading to respiratory disorders. Asia Pacific dominated the market due to a large geriatr...
November 27, 2025
Based on market forecasts, the global human growth hormone injection market, projected at USD 4.53 billion in 2025, is expected to reach USD 8.54 billion by 2035, growing at a CAGR of 6.55% over the forecast period. The human growth hormone injection market is growing as approval of this hormone for healthcare applications and extensive, controvers...
November 27, 2025
According to market projections, the global sinusitis drugs market, valued at USD 2.33 billion in 2025, is anticipated to reach USD 4.16 billion by 2035, growing at a CAGR of 5.96% over the next decade. The growing research activities and increasing R&D investments drive the global market. North America dominated the global market due to a robu...
November 26, 2025
Market insights predict the global probiotic industry will increase from USD 114.31 billion in 2025 to USD 429.01 billion by 2035, achieving a CAGR of 14.14%. The probiotics market is growing due to growing awareness about gut health. Asia Pacific is leading the market due to a large consumer base....
November 26, 2025
Market insights predict the global asthma and COPD medicines industry will increase from USD 13.10 billion in 2025 to USD 19.32 billion by 2035, achieving a CAGR of 3.96%. The asthma and COPD medicines market is growing due to the increasing prevalence of these diseases, driven by smoking and pollution, and an increasing and aging worldwide populat...
November 26, 2025
According to market projections, the global modified antibody market, valued at USD 3.10 billion in 2025, is anticipated to reach USD 7.36 billion by 2035, growing at a CAGR of 9.04% over the next decade. The biopharmaceutical contract manufacturing market is growing rapidly, fueled by rising outsourcing and biologics demand. The report includes ...
November 25, 2025
According to market projections, the blood product sector is expected to grow from USD 39.96 billion in 2025 to USD 62.65 billion by 2035, reflecting a CAGR of 4.6%, driven by rising demand in surgeries, cancer care, and trauma cases. North America leads in revenue, while Asia-Pacific shows the fastest growth. RBCs and blood stations dominate the m...
November 25, 2025
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segments, regional distribution (NA, EU, APAC, LA, MEA), manufacturer data, competitive benchmarking, value...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com